Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,874.10
-32.95 (-1.73%)
BSENSE

Dec 05

BSE+NSE Vol: 3.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Sep'24
Net Sales
145.30
119.85
167.41
0.00
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
145.30
119.85
167.41
0.00
Raw Material Cost
100.44
91.08
125.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.41
-6.66
-1.23
0.00
Employee Cost
8.30
7.63
9.70
0.00
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.67
3.64
4.59
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
6.14
7.17
12.09
0.00
Total Expenditure (Excl Depreciation)
122.96
102.86
150.16
0.00
Operating Profit (PBDIT) excl Other Income
22.34
16.99
17.25
0.00
Other Income
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
22.34
16.99
17.25
0.00
Interest
7.73
6.53
8.15
0.00
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
14.61
10.46
9.10
0.00
Depreciation
1.89
1.42
1.84
0.00
Profit Before Tax
12.71
9.04
7.26
0.00
Tax
3.27
2.27
1.26
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
9.43
6.77
6.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
9.43
6.77
6.00
0.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
9.43
6.77
6.00
0.00
Equity Capital
4.72
4.72
4.72
4.72
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
Earnings per share (EPS)
19.98
14.34
12.71
0.0
Diluted Earnings per share
19.98
14.33
12.71
0.0
Operating Profit Margin (Excl OI)
15.56%
14.23%
10.43%
0.0%
Gross Profit Margin
10.17%
8.76%
5.5%
0.0%
PAT Margin
6.57%
5.67%
3.63%
0.0%
Public Share Holdings (%)
51.07%
51.07%
51.07%
50.84%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 34.33% vs 31.19% in Sep 2024

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 127.87% vs 8.38% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 60.33% vs 45.21% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 45.57% vs 83.10% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Fredun Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
145.30
111.05
34.25
30.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
145.30
111.05
34.25
30.84%
Raw Material Cost
100.44
54.05
46.39
85.83%
Purchase of Finished goods
0.00
1.02
-1.02
-100.00%
(Increase) / Decrease In Stocks
4.41
-0.44
4.85
1,102.27%
Employee Cost
8.30
13.31
-5.01
-37.64%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
3.67
-0.01
3.68
36,800.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6.14
17.77
-11.63
-65.45%
Total Expenditure (Excl Depreciation)
122.96
85.70
37.26
43.48%
Operating Profit (PBDIT) excl Other Income
22.34
25.35
-3.01
-11.87%
Other Income
0.00
0.90
-0.90
-100.00%
Operating Profit (PBDIT)
22.34
26.25
-3.91
-14.90%
Interest
7.73
2.84
4.89
172.18%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
14.61
23.41
-8.80
-37.59%
Depreciation
1.89
4.96
-3.07
-61.90%
Profit Before Tax
12.71
18.45
-5.74
-31.11%
Tax
3.27
4.33
-1.06
-24.48%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
9.43
14.12
-4.69
-33.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
9.43
14.12
-4.69
-33.22%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
9.43
14.12
-4.69
-33.22%
Equity Capital
4.72
10.38
-5.66
-54.53%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
19.98
13.60
6.38
46.91%
Diluted Earnings per share
19.98
13.60
6.38
46.91%
Operating Profit Margin (Excl OI)
15.56%
22.83%
0.00
-7.27%
Gross Profit Margin
10.17%
21.08%
0.00
-10.91%
PAT Margin
6.57%
12.71%
0.00
-6.14%
Public Share Holdings (%)
51.07%
0.00%
51.07
51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 143.59 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 20.26% vs -27.83% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 34.33% vs 31.19% in Sep 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 9.73 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 43.72% vs -4.24% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 127.87% vs 8.38% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.35 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 31.55% vs -2.58% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 60.33% vs 45.21% in Sep 2024

Quarterly - Interest
Interest 7.73 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 18.38% vs -19.88% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 45.57% vs 83.10% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.57%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024